Location History:
- Kanagawa, JP (2015 - 2021)
- Yokohama, JP (2022)
- Fujisawa, JP (2017 - 2023)
Company Filing History:
11 out of 1,179 
1 out of 712 
1 out of 2 Years Active: 2015-2023
Title: Innovations by Jumpei Aida: A Journey Through Patents and Collaborations
Introduction
Jumpei Aida, an accomplished inventor located in Kanagawa, Japan, holds a remarkable portfolio of 12 patents. His work primarily focuses on the development of compounds with therapeutic applications, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest innovations is a patent concerning a heterocyclic compound designed to antagonize the NMDA receptor containing the NR2B subunit. This compound offers promising benefits for the prophylaxis and treatment of conditions such as major depression, bipolar disorder, migraine, pain, and dementia-related symptoms. The invention is defined by a specific formula, wherein each symbol is carefully outlined in the detailed description. Another significant patent involves substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles, which act as inhibitors of the human cGAS enzyme. These compounds are particularly valuable as they present potential therapeutic agents for treating cGAS-related autoimmune diseases.
Career Highlights
Jumpei Aida has established a notable career, working with leading companies in the pharmaceutical field. His tenure at Takeda Pharmaceutical Company Limited and The Rockefeller University highlights his involvement in prestigious research environments, contributing significantly to innovative drug development.
Collaborations
Throughout his career, Aida has collaborated with esteemed colleagues, including Shuhei Ikeda and Hideyuki Sugiyama. These partnerships have not only enriched his research but have also facilitated the exchange of knowledge, enhancing the quality of his inventions.
Conclusion
Jumpei Aida stands out in the realm of innovation, with a focus on creating compounds that address critical health issues. His extensive patent portfolio and collaborative efforts underscore his contributions to the pharmaceutical field, driving forward the frontier of medical treatments. The impact of his work is likely to resonate in the industry for years to come.